The Selection and Use of Essential Medicines - WHO Technical Report Series, No. 920
(2003; 137 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documento1. Introduction
Ver el documento2. Open session
Cerrar esta carpeta3. Update on current activities
Ver el documento3.1 Dissemination of the previous report of the Expert Committee (including the 12th Model List)
Ver el documento3.2 The twenty-fifth anniversary of the WHO Model List of Essential Medicines
Ver el documento3.3 The WHO model formulary
Ver el documento3.4 Review of the New Emergency Health Kit
Ver el documento3.5 Review of essential medicines for reproductive health
Ver el documento3.6 Report of an ad hoc Advisory Committee on priority vaccines
Ver el documento3.7 The WHO Essential Medicines Library
Cerrar esta carpeta3.8 Promoting rational use of essential medicines
Ver el documento3.8.1 Update on activities to contain antimicrobial resistance
Ver el documento3.8.2 Guidelines for drugs and therapeutic committees
Ver el documento3.8.3 WHO database on rational drug use studies
Abrir esta carpeta y ver su contenido4. Changes made in revising the Model List
Abrir esta carpeta y ver su contenido5. Reviews of sections of the Model List
Ver el documento6. Priorities for future reviews
Abrir esta carpeta y ver su contenido7. Recommendations
Ver el documentoReferences
Ver el documentoAnnex 1 The 13th WHO Model List of Essential Medicines
Ver el documentoAnnex 2 The Anatomical Therapeutic Chemical (ATC) classification system1
Ver el documentoAlphabetical list of essential medicines (with ATC classification code numbers)
Ver el documentoSelected WHO Publications of Related Interest
 

3.8.3 WHO database on rational drug use studies

In 1985, WHO defined rational use of medicines as requiring that "patients receive medications appropriate to their clinical needs, in doses that meet their own requirements, for an adequate period of time, and at the lowest cost to them and their community" (11). Since then, the International Network for the Rational Use of Drugs (INRUD) has been formed and much work has been undertaken by WHO, INRUD and other organizations in order to develop and use indicators for monitoring medicine use and to initiate intervention studies to promote rational use.

The impact of these efforts is, however, not very well known. WHO is currently developing a database on the rational use of medicines, the main objective of which is to provide a general overview of existing drug use patterns in primary health care settings in developing countries over time, and to study the impact of different types of interventions on improving the use of medicines. This type of information is vital for developing a global multifaceted strategy for the promotion of rational use of medicines and for assisting regions and countries seeking to prioritize their own activities in this area.

Work has already started on identifying relevant published and unpublished studies from both INRUD and WHO sources, and entering the pertinent data (e.g. prescriber and facility type, disease pattern, methodology, outcome indicators) into the database. The data will be analysed by country and region, and over time (1990-2003), and then used to assess the impact of different kinds of interventions to promote the rational use of medicines. The database has been designed so as to be compatible with other WHO databases; this will allow future analysis of the impact of health systems and policies on the rational use of medicines.

At the time of the present meeting, 1160 articles from the INRUD bibliography covering the period 1997-2001 had been screened, and from these, 92 data records extracted and entered into the database. A preliminary analysis of the data will be presented at the International Conference on Improving Use of Medicines (ICIUM) in 2004 and is intended as an advocacy tool for promoting rational use of medicines in the developing world. Future work includes entering data for earlier years and a systematic analysis of the full data set. There are also plans to expand the scope of the database to include such information as hospital-based drug use, self-medication, patients' adherence to treatment and diagnostic accuracy. The database will be made available to interested researchers and policy makers through the Internet.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 19 enero 2012